PD-1 Blockade in Anaplastic Thyroid Carcinoma

PURPOSE: Anaplastic thyroid carcinoma is an aggressive malignancy that is almost always fatal and lacks effective systemic treatment options for patients with BRAF-wild type disease. As part of a phase I/II study in patients with advanced/metastatic solid tumors, patients with anaplastic thyroid car...

Descripción completa

Detalles Bibliográficos
Autores principales: Capdevila, Jaume, Wirth, Lori J., Ernst, Thomas, Ponce Aix, Santiago, Lin, Chia-Chi, Ramlau, Rodryg, Butler, Marcus O., Delord, Jean-Pierre, Gelderblom, Hans, Ascierto, Paolo A., Fasolo, Angelica, Führer, Dagmar, Hütter-Krönke, Marie Luise, Forde, Patrick M., Wrona, Anna, Santoro, Armando, Sadow, Peter M., Szpakowski, Sebastian, Wu, Hongqian, Bostel, Geraldine, Faris, Jason, Cameron, Scott, Varga, Andreea, Taylor, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476256/
https://www.ncbi.nlm.nih.gov/pubmed/32364844
http://dx.doi.org/10.1200/JCO.19.02727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476256/
https://www.ncbi.nlm.nih.gov/pubmed/32364844
http://dx.doi.org/10.1200/JCO.19.02727

Ejemplares similares